Novartis Aktie
WKN: 907122 / ISIN: US66987V1098
12.10.2017 23:00:00
|
BTB announces its distribution for the month of October 2017
MONTRÉAL, Oct. 12, 2017 /CNW Telbec/ - BTB Real Estate Investment Trust (TSX: BTB.UN) announced today that the monthly cash distribution for the month of October 2017 is $0.035 per unit, representing $0.42 per unit on an annualized basis. The cash distribution will be paid on November 15, 2017 to unitholders of record on October 31, 2017.
About BTB
BTB is a real estate investment trust listed on the Toronto Stock Exchange. BTB is an important owner of properties in eastern Canada. Today, BTB owns 70 retail, office and industrial properties for a total leasable area of 5.1 million square feet. BTB's asset value is approximately $675M. The objectives of BTB are: i) to grow its revenues from its assets to increase distributable income and therefore fund distributions; (ii) to maximize the value of its assets through dynamic management of its properties in order to sustain the long-term value of its units; and (iii) to generate cash distributions that are fiscally beneficial to unitholders.
BTB offers a distribution reinvestment plan to unitholders whereby the participants may elect to have their monthly cash distribution reinvested in additional units of BTB at a price based on the weighted average price for BTB's Units on the Toronto Stock Exchange for the five trading days immediately preceding the distribution date, discounted by 3%.
SOURCE BTB Real Estate Investment Trust

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novartis AG (Spons. ADRS)mehr Nachrichten
29.04.25 |
Novartis-Aktie im Plus: Prognose nach starkem Start ins Jahr erhöht (Dow Jones) | |
28.04.25 |
Ausblick: Novartis präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net) | |
14.04.25 |
Erste Schätzungen: Novartis zieht Bilanz zum jüngsten Jahresviertel (finanzen.net) | |
11.04.25 |
Novartis-Aktie zieht an: Milliardenoffensive - Novartis kündigt Großinvestition in US-Markt an (Dow Jones) | |
11.02.25 |
Novartis investiert Milliarden in US-Unternehmen Anthos Therapeutics - Aktie höher (Dow Jones) | |
31.01.25 |
Novartis-Aktie zieht an: Novartis erhöht Dividende nach beeindruckendem Umsatz- und Gewinnplus (finanzen.at) | |
30.01.25 |
Ausblick: Novartis öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) | |
21.01.25 |
Novartis-CEO: Gesundheitspolitik der US-Regierung könnte sich unter Trump verbessern - Novartis-Titel höher (Dow Jones) |
Analysen zu Novartis AG (Spons. ADRS)mehr Analysen
Aktien in diesem Artikel
Novartis AG (Spons. ADRS) | 96,60 | 1,47% |
|